STREAMEX CORP. Inventory
STREAMEX CORP. (STEX) had Inventory of $219.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2024-04-16
- 2023-09-30: Inventory, Net $219.00K.
- 2023-06-30: Inventory, Net $189.00K.
- 2023-03-31: Inventory, Net $345.00K.
- 2022-12-31: Inventory, Net $336.00K.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2023-09-30 | $219.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $189.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $345.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $336.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $1.69M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.03M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.03M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.88M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.88M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $731.05K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $649.94K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $768.00K 10-K · filed 2022-03-31 | $768.32K 10-K · filed 2021-03-15 |
| 2020-09-30 | $806.41K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $800.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $800.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $578.00K 10-K · filed 2021-03-15 | $577.69K 10-K · filed 2020-03-13 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |